Platform Biotechnology
A next-generation platform for building differentiated therapeutic solutions
ProstaNOva Therapeutics is a platform-based biotechnology company advancing new therapeutic programs grounded in prostaglandin biology and nitric-oxide donor logic, with an initial pilot focus on critical limb ischemia and broader multi-indication potential.
About the Company
ProstaNOva Therapeutics is a multi-program biotechnology platform. Our first pilot program is focused on critical limb ischemia, while the broader scientific platform has the potential to support development across additional therapeutic areas over time.
What We Do
Four commitments that define how the platform is built and advanced.
PLATFORM
Platform-based therapeutic development
STRATEGY
Multi-program scientific strategy
PILOT
CLI pilot development pathway
PARTNERS
A focus on strategic partnerships
Vision
ProstaNOva Therapeutics brings together platform science, translational development logic, and the potential for selective partnerships to build programs and create long-term value.